Next Article in Journal
β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
Next Article in Special Issue
Drug Conjugation Induced Modulation of Structural and Membrane Interaction Features of Cationic Cell-Permeable Peptides
Previous Article in Journal
AGAP2: Modulating TGFβ1-Signaling in the Regulation of Liver Fibrosis
Previous Article in Special Issue
Novel ACE Inhibitory Peptides Derived from Simulated Gastrointestinal Digestion in Vitro of Sesame (Sesamum indicum L.) Protein and Molecular Docking Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations

by
Stefano Borocci
1,2,
Giulia Della Pelle
1,
Francesca Ceccacci
3,
Cristina Olivieri
4,
Francesco Buonocore
1 and
Fernando Porcelli
1,*
1
Department for Innovation in Biological, Agrofood and Forest Systems, University of Tuscia, 01100 Viterbo, Italy
2
CNR—Institute for Biological Systems, Via Salaria, Km 29.500, 00015 Monterotondo, 00015 Rome, Italy
3
CNR—Institute for Biological Systems, Sede Secondaria di Roma-Meccanismi di Reazione, 00185 Rome, Italy
4
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(4), 1401; https://doi.org/10.3390/ijms21041401
Submission received: 31 December 2019 / Revised: 12 February 2020 / Accepted: 17 February 2020 / Published: 19 February 2020
(This article belongs to the Special Issue Membrane–Peptide Interactions: From Basics to Current Applications)

Abstract

:
Antimicrobial peptides have been identified as one of the alternatives to the extensive use of common antibiotics as they show a broad spectrum of activity against human pathogens. Among these is Chionodracine (Cnd), a host-defense peptide isolated from the Antarctic icefish Chionodraco hamatus, which belongs to the family of Piscidins. Previously, we demonstrated that Cnd and its analogs display high antimicrobial activity against ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species). Herein, we investigate the interactions with lipid membranes of Cnd and two analogs, Cnd-m3 and Cnd-m3a, showing enhanced potency. Using a combination of Circular Dichroism, fluorescence spectroscopy, and all-atom Molecular Dynamics (MD) simulations, we determined the structural basis for the different activity among these peptides. We show that all peptides are predominantly unstructured in water and fold, preferentially as α-helices, in the presence of lipid vesicles of various compositions. Through a series of MD simulations of 400 ns time scale, we show the effect of mutations on the structure and lipid interactions of Cnd and its analogs. By explaining the structural basis for the activity of these analogs, our findings provide structural templates to design minimalistic peptides for therapeutics.

Graphical Abstract

1. Introduction

Antimicrobial resistance towards widely used antibiotics has become a global health crisis [1]. The diffusion of multidrug resistant (MDR) bacteria is widespread and infections caused by human pathogens often require multiple treatment, which not always effective. The United States Food and Drug Administration listed 21 qualifying pathogens that pose serious threats to public health (part 317.2 of CFR Annual Print Title 21 Food and Drugs) [2]. The search for new antimicrobial drugs to replace or integrate classical antibiotics is imperative. Many different alternatives have been proposed as potential drugs for the treatment of resistant bacterial strains such as antibodies, vaccines [3], bacteriophages [4,5], and antimicrobial peptides [6,7]. Antimicrobial peptides (AMP) represent the first line of innate immune system and are present in plants, microorganisms, and animals [8,9]. The Antimicrobial Peptide Database (APD: aps.unmc.edu/AP) comprises about 3100 entries from six kingdoms (bacteria, archaea, protists, fungi, plants, and animals) with antibacterial, antiviral, antifungal, and antiparasitic activity. Despite their different primary sequences and structures, AMPs share common properties such as cationicity, charge distribution, hydrophobicity, and amphipathicity [10,11]. Amphipathic cationic α-helical peptides have been proposed as potential antimicrobial agents due to their broad-spectrum and instantaneous antimicrobial activity [12,13,14,15,16]. However, a clear relationship between amino acid composition and antimicrobial activity still remains to be elucidated.
Antimicrobial peptides perform their function through several mechanisms such as inhibition of protein and/or DNA synthesis or inhibition of specific enzymatic pathways [17]. However, the majority of AMPs interacts with the anionic bacterial membranes and kills bacteria via cell membrane disruption [18,19]. The amphipathic character of AMP drives the interaction with the bacterial cell membrane and the subsequent disruption that kills the target cells rapidly. Two main mechanisms have been proposed: (a) pore formation and (b) carpet-like model of aggregation. The latter involves essentially four major mechanistic steps: attraction, attachment, insertion, and permeation [20,21,22,23]. The first two steps, attraction of peptide toward the cell membrane and attachment, are driven by electrostatic interactions between the positively charged AMP and the negatively charged membrane of bacteria. The two succeeding steps, insertion and permeation, are driven by the amphipathic distribution of hydrophobic and hydrophilic residues on peptide [24,25].
Chionodracine (Cnd) is a 22-residue antimicrobial peptide (AMP) isolated from the gills of the Antarctic fish Chionodraco hamatus belonging to Piscidins [26], a family of α-helical antimicrobial peptides identified in teleost fish [27]. In previous studies, we isolated Cnd [28] and showed that this short peptide binds lipid vesicles, disrupting the outer membrane of E.coli and Psycrobater sp. Upon membrane interactions, Cnd folds into a dynamic α-helix [29]. Based on our findings, we exploited Cnd as starting scaffold to design a series of mutants with higher positive charge to increase their antimicrobial activity and selectivity towards prokaryotic organisms. For drug design purposes, an ideal antimicrobial peptide should have maximal antimicrobial activity and minimal cytotoxicity towards eukaryotic cells. We then characterized the interactions of these peptides with model lipid vesicles and showed that they are active against MDR nosocomial bacteria strains [30,31].
In this paper, we studied more in details the structural basis for the differences in the bactericidal activity between Cnd and the two promising Cnd analogs, Cnd-m3 and Cnd-m3a reported in our previous studies [30,31]. Specifically, we first determined the secondary structure of Cnd-m3 and Cnd-m3a in presence of different LUVs and, afterwards, we performed all-atom MD simulations to elucidate the complex mechanism of peptide-lipid interactions and the associated conformational changes. These data could be of interest to identify the mutations useful to design new analogs with enhanced biologic activity against human bacterial pathogens.

2. Results

2.1. Peptide Design and Physico-Chemical Properties

Cnd-m3 and Cnd-m3a are synthetic antimicrobial peptides designed by modifying the parent peptide Cnd (Table 1) [30,31] found in the gills of the Antarctic teleost fish Chionodraco hamatus.
The number of positive charges is critical for the activity of AMP due to the interaction with the negatively charged membranes of bacteria [32]. We modified the parent peptide by introducing charged residues (i.e., Lysines) to increase its net positive charge. For Cnd-m3, Ser-11, Ser-22, and three Histidines in position 4, 15 and 17, respectively, were replaced by Lysines. The net positive charge increased from +2 to +7 compared to Cnd. For the Cnd-m3a mutant, Ile-9, positioned in the middle of the hydrophobic face of peptide, was replaced by Lysine, resulting in a net positive charge of +8. The helical representation of Cnd and its analogs is reported in Figure 1. The mutations increased the electrostatic repulsions between charged residues (i -> i + 3 and i -> i + 4) on the polar face of the putative helical structure but had no effect on the nonpolar face. Cnd and Cnd-m3 displayed 11 hydrophobic interactions. The thermodynamic characterization of the interaction between peptides and vesicles made 100% of POPC and of POPC/POPG (molar ratio 70:30) was carried out and the data show that both peptides display a marked preference for lipid mixtures mimicking the prokaryotic cell membranes (POPC/POPG) [30,31]. Moreover, we showed that the antimicrobial activity of Cnd-m3 with respect to Cnd increased against MDR nosocomial bacteria strains. For instance, we showed that the MIC decreased by two times for MRSA (Methicillin resistant Staphylococcus aureus) to 30 times for KPC (Klebsiella pneumoniae carbapenemase) [30]. The antimicrobial activity of Cnd-m3a decreased as compared to Cnd-m3, however, its selectivity ratio increased from 2.4 to 4.9 [31]. Moreover, in silico analysis, carried out using the Peptide Cutter tool available on EXPASY Server (https://web.expasy.org/peptide_cutter/), showed that both mutants were more resistant than Cnd to proteolytic degradation, especially towards the chymotrypsin-low specificity.

2.2. Secondary Structure Analysis by Circular Dichroism

The secondary structure of Chionodracine and Cnd-analogues was investigated by CD spectroscopy. The experiments were carried out at 25 °C in buffered LUVs, consisting of either 100% POPC or a 70:30 mixture of POPC/POPG. CD is a rapid and convenient spectroscopic technique for determining the conformational transition of proteins and peptides. We studied the conformational transitions of the three peptides upon interaction with anionic and zwitterionic membrane mimicking prokaryotic and eukaryotic environments, respectively. Typical titration curves in the presence of increasing amounts of lipid vesicles are shown in Figure 2. Increasing peptide:lipid ratios (P:L) were tested in a range between 1:0 and 1:60.
In the absence of lipid vesicles (P:L = 1:0), all the peptides were essentially unstructured, with CD spectra showing a minimum at 200 nm characteristic of a random coil structure (Black curve). In the presence of POPC vesicles, mimicking the eukaryotic cell membrane, the CD spectra of both Cnd and Cnd-m3 revealed two minima at ~208 and ~222 nm, which increase with the lipid concentration, and a strong maximum at ~190 nm, typical of α-helix conformation. The rotational strength of the bands at 208 and 222 nm are often used as an index of the presence of helical structures [33,34]: for α-helical polypeptides the intensities of the two bands are almost the same. The analysis of shape of the CD spectrum as well as the ratio θ222nm/θ208nm ~ 1 confirms that Cnd and Cnd-m3 fold in a canonical α-helix in presence of lipid vesicles. For the Cnd-m3a mutant, the CD spectra do not change significantly upon addition of lipids. In the absence of lipids, the spectra show a minimum at ~200 nm, which is typical of a random coil conformation. In presence of increasing amounts of POPC LUVs, this minimum shifts to 206 nm and a very small signal at 222 nm appears only upon addition of a large excess of LUVs (P:L ~ 1:60). The behavior of Cnd upon interaction with POPC/POPG (70:30) LUVs is similar to that observed in the presence of POPC vesicles, i.e., the peptide folds in a α-helix conformation at low P:L ratios. In the case of Cnd-m3, the value of θ222nm are higher as compared to those observed in POPC, indicating that Cnd-m3 is more prone to adopt a helical conformation in presence of negatively charged membranes. The helicity becomes even more apparent at a P:L ratio of 1:4 and reaches the maximum at 1:30. From the analysis of CD spectra, it is apparent that in presence of POPC/POPG LUVs the value of ratio θ222/θ208 can be either less than 1 or greater than 1 depending on the L/P ratio. However, the use of this ratio to distinguish between different helical conformations, such as 310 or α, is not always possible and should be used with extreme caution, since the ratio depends also by the helical chain length, and aggregation to form helical bundle [33,35].
For Cnd-m3a, the CD spectra in presence of POPC/POPG (70:30) LUVs are similar to those in POPC, but the θ222nm values are higher. The values of θ222nm and the percentage of helicity are reported in Table 2. The molar ellipticities in POPC correspond to a helical fraction of 0.63, 0.31, and 0.12 for Cnd, Cnd-m3, and Cnd-m3a, respectively. The helical fractions (fα) in the presence of POPC/POPG were calculated according to equation 1(see Material and Methods) and resulted to be 0.64, 0.79, and 0.14, respectively. For each peptide, the structural differences detected in POPC and POPG are reported as the molar ellipticity ratio at 222 nm in POPC and POPC/POPG lipid systems:   θ 222 n m P C / θ 222 n m P C P G [36]. While for Cnd the helicities in POPC and POPC/POPG vesicles were similar, for Cnd-m3, the increased amphipathicity (µH = 0.68) favored the increase of helicity in the presence of negatively charged vesicles (i.e., POPC/POPG). The large decrease of helicity for Cnd-m3a with respect to Cnd and Cnd-m3 was probably due to the disruption of the hydrophobic surface caused by the substitution of Ile with the positively charged Lysine in position 9.
These results agree with the partition data previously published, showing partition constants for Cnd and Cnd mutants higher in POPC/POPG than in pure POPC [30,31].

2.3. Steady-State Anisotropy

We also evaluated the interactions of Cnd and its derived peptides with lipid bilayers formed by POPC and POPC/POPG LUVs using steady-state anisotropy (r) of DPH (1,6-Diphenyl-1,3,5-hexatriene). DPH is a compound whose fluorescence anisotropy depends on the membrane fluidity [37]. DPH acts as a rod-like hydrophobic probe rotating in the bilayer structure and is located between the acyl chains of the lipids. Due to the presence of the lipid chains, its molecular rotation is restricted, i.e., in the presence of a high organized bilayer the rotational freedom is limited. Changes in the organization of the lipid bilayer, e.g., increasing fluidity, affect the rotational freedom of DPH and the anisotropy will change. In Figure 3, the normalized anisotropy of DPH measured at 25 °C at different concentrations of peptides is reported.
Fluorescence experiments showed that peptides interact with LUVs of different composition perturbing the hydrocarbon chain region in different ways. In the presence of POPC, only Cnd is able to perturb the anisotropy of DPH; while Cnd-mutants do not. In presence of negatively charged lipid POPC/POPG, both Cnd and Cnd-m3 perturb the anisotropy of DPH while Cnd-m3a does not. The detected increase of the anisotropy of DPH suggests that the interaction with Cnd and Cnd-m3 significantly decreased the fluidity of lipid bilayer. This latter effect could be correlated to a moderate structural organization upon interaction with the peptide. For both LUVs, Cnd-m3a does not induce changes in membrane fluidity. Thus, the variation of membrane fluidity is not directly correlated with the antibacterial activity. In fact, all the peptides showed antimicrobial activity but different values of DPH anisotropy. However, these differences could be related with the different mode of action of the three peptides. In fact, Cnd and Cnd-m3 are membranolytic peptides [29,30] while Cnd-m3a can permeate through the bacteria cell membrane and directly interact with intracellular nucleic acid [31]. These results in combination with CD investigations suggest that the interaction of Cnd and Cnd-m3 with LUVs is different from that of Cnd-m3a and such diversity is correlated with a different propensity to adopt a helical conformation.

2.4. Molecular Dynamics Simulation

To characterize the effects of mutations on Cnd-lipid interactions, we carried out atomistic MD simulations in different explicit environments such as water, TFE/water mixture, and lipid membranes composed of 100% POPC and 70:30 mixture of POPC:POPG. In the following sections, we report the results observed in of the different environments.

2.4.1. Water and TFE/Water Solution

Figure 4 shows the time evolution of the secondary structures for Cnd, Cnd-m3, and Cnd-m3a simulated in water and TFE/water (30% v/v) solutions. According to the NMR structure of Cnd [29] and the model of Cnd-m3 and Cnd-m3a obtained by I-TASSER bioinformatics tool, Cnd and Cnd-m3 were initially in α-helix conformation, while for Cnd-m3a the initial structure showed only ~50% of α-helix. The simulation of Cnd in water showed a loss of the α-helix conformation (Figure 4A) and the adoption of an unstructured conformation with the formation of short and transient α-helix involving four amino acids. Conversely, in TFE/water mixture, Cnd conserved the α-helix throughout the entire simulation (Figure 4B) and the structure is similar to the NMR structure obtained in DPC micelles, with a backbone RMSD of 0.12 nm. In water, Cnd-m3 is more flexible than Cnd and remains essentially unstructured during simulation with the formation of two short antiparallel β-sheets in the C-terminal regions of peptide in the last 10 ns (Figure 4C). Similar to Cnd, the simulation of Cnd-m3 in TFE/water shows the presence of a stable α-helix that is substantially preserved throughout the entire simulation (Figure 4D). The initial structure of Cnd-m3a contains 10 residues of the C-terminus in an α-helical conformation; whereas the N-terminus is unstructured. This conformation is persistent both in water and TFE/water (Figure 4E,F).
Overall, all peptides showed that in TFE/water (30% v/v) their initial α-helix structures are stabilized and preserved during the MD simulation.

2.4.2. Peptides with Lipid Bilayers

The folding of peptide at water/membrane surface is a process with a time scale in the range of milliseconds to seconds. Therefore, to reduce computational cost, we studied the interactions of Cnd and its mutants with lipid bilayer starting from their equilibrated conformations in TFE/water. The α-helical of peptides were taken parallel to lipid surface with a distance of 0.5 nm between the center of mass of peptide and the phosphate atoms of lipids. Cnd placed close to the surface of bilayer of POPC and POPC/POPG conserves a helicity of 55% ± 3% and 50% ± 5%, respectively (Figure S1). Upon interaction with the POPC head groups Cnd is adsorbed on the membrane/water interface, pointing its hydrophobic residues toward the hydrophobic region of bilayer; whereas the charged Lys-14 and Arg-7 and the Histidine residues (His-4, His-15, His-17) are oriented towards the bulk water phase (Figure 5A). In POPC/POPG bilayer, Cnd shows a similar orientation of the amphipathic helix as observed for the simulation in POPC. However, the peptide snorkels toward the water/membrane interface due to the presence of arginine and histidine residues that interact with the phosphate groups (Figure 5B).
The presence of a high number of lysines, seven in Cnd-m3 and eight in Cnd-m3a, plays a crucial role on the structure of peptides and on their interactions with lipids. Cnd-m3 and Cnd-m3a, located on the surface of POPC bilayer, conserved only a fraction of the initial helicity (25% ± 4% for Cnd-m3 and 28% ± 3% for Cnd-m3a) in the middle region of the peptide. (Figure S1) Lysines and arginines are oriented toward the water phase and the interaction of Cnd-m3 and Cnd-m3a with lipid hydrocarbon chains is due mainly to their hydrophobic residues. In presence of POPC/POPG, the helicity of Cnd-m3 and Cnd-m3a is similar to the simulations in POPC. However, the interactions between lysines and arginines with the phosphate groups of lipid are more persistent (Figure 5C–F). Figure 6 shows the mass density distribution of phosphate and nitrogen atoms of lipids (POPC and POPC/POPG) and the lysine residues of Cnd-m3 and Cnd-m3a calculated, in the final 100 ns of trajectory with respect to the center of the lipid bilayer.
The analysis of the mass density shows that in the interaction with POPC bilayer the l lysine residues of Cnd-m3 and Cnd-m3a are oriented toward the water phase far from the phosphate groups (Figure 6A,C). On the contrary, in the presence of negative charged lipid bilayers (POPC/POPG, Figure 6B,D), the density of lysine residues overlaps with that of the phosphate groups, indicating significant interactions between the charged groups of peptides and lipids. When inserted perpendicularly to the lipid bilayer, the peptides show a more defined conformation with respect to the peptides parallel to the surface of bilayer. Cnd embedded into POPC and POPC/POPG bilayer preserves a stable α-helical conformation during the entire simulation (400 ns) with a helicity of 82% ±2% and 81% ± 2% (18 residues), respectively. In POPC and POPC/POPG bilayers, Cnd adopts a more helical structure with respect to both Cnd-m3 and Cnd-m3a mutants. The helical content of Cnd-m3 in POPC is 45% ±2% (10 residues) and increases to 65% ± 3% (14 residues) in the presence of POPC/POPG.
Cnd-m3a, embedded in POPC and POPC/POPG bilayer, shows a stable α-helix in the C-terminus with a helical content of 47% ± 3% in POPC and 44% ± 3% in POPC/POPG. Figure 7 shows the position of the peptides with respect to the lipid bilayers (POPC and POPC/POPG) at the end of each MD simulation. For Cnd-m3 and Cnd-m3a, the insertion of lysine residues into the hydrophobic core of lipid bilayer induces a perturbation of the lipid aggregate. In fact, the hydrophobic side chains of lysines, positively charged, orient toward the negative charged phosphate group of lipids (snorkel effect [38]). As shown in Figure 7, the lipid molecules close to the peptide change partially the orientation to have favorable interactions. The presence of lysine residues in the hydrophobic regions of bilayer determines also the penetration of water molecules (5–7 molecules) that interact with the charged amino acid by hydrogen bonds. The presence of water molecules in the hydrophobic core, together to the presence of charged lysines, contributes to destabilize the lipid bilayer, which shows a reduced thickness in the region near the peptides.
The destabilizing effects of Cnd, Cnd-m3 and Cnd-m3a on the structure of lipid bilayer can be evidenced by analyzing the change of thickness of lipid bilayer during the last 100 ns of each MD simulations. Figure 8 shows the 3D density maps of time averaged thickness of POPC and POPC/POPG in presence of Cnd, Cnd-m3 and Cnd-m3a embedded in lipid bilayer. The blue color corresponds to the region of bilayer with low values of thickness and the red color to the region with high thickness. The peptides embedded in bilayer are localized in the region with the lowest thickness.
As shown in Figure 8 the thickness of lipid bilayer was perturbed around the antimicrobial peptides. The largest structural deformation of lipid bilayer, both in POPC and POPC/POPG, was observed in the case of Cnd-m3a with the average bilayer thickness in vicinity of the peptide decreased approximately up to 1.9 nm. In the case of Cnd-m3 the averaged thickness of lipid bilayer close to peptide was approximately of 2.5 nm. Cnd induces a perturbation of thickness smaller with respect to Cnd-m3a and Cnd-m3 with the average bilayer thickness in vicinity of the peptide approximately of 2.9 nm.

3. Discussion

Alternative approaches are needed to neutralize antibiotic resistant diseases. Host defense peptides such as AMPs offer a good starting model to obtain more active antimicrobial agents. More than 3000 AMPs are reported in public database [39] giving a good source of information to delineate strategies for the AMP design. Here, we selected the two Cnd analogues, which showed a potent antimicrobial activity against multidrug resistant bacteria and investigated their interaction with model membranes in order to gain insight on such interactions that could be useful for the rational design of novel antimicrobial agents [30,31]. These analogues were designed considering the number of positive charges, the distribution of hydrophobic residues and the location of specificity determinants. According to Hodges and co-workers specificity determinants are positively charged residues in the middle of the non-polar face of the hypothetical amphipathic helix (Figure 1) [40]. The role of these residues is to increase the selectivity between prokaryotic and eukaryotic membranes. Moreover, it has been established that high hydrophobicity on the non-polar face correlates with peptide self-aggregation to form dimers or oligomers and with a decrease in the antimicrobial activity [41]. Selective toxicity, killing bacterial pathogens without damaging eukaryotic cells, is crucial for the development of AMP. Recently, we demonstrated the increase in selectivity of Cnd analogs as measured by the selectivity ratios, defined by the ratio between the partition constants measured in POPC/POPG and POPC. Higher values indicate the preference of peptide to partition into anionic vesicles, mimicking the bacterial cell membrane and we found values of 1.43, 2.39 and 4.90 for Cnd, Cnd-m3 and Cnd-m3a, respectively [30,31]. We used CD spectroscopy and all atoms MD simulations to elucidate peptide conformational changes the underlay the complex mechanism of peptide-lipid interactions.
CD spectroscopy experiments revealed a difference in the secondary structure adopted by peptides in presence of various membrane mimicking environments. All peptides adopted a random coil conformation in phosphate buffer and undergo a transition to a more ordered conformation in the presence of anionic and zwitterionic LUVs. However, Cnd and Cnd-m3 fold in an α-helical conformation, both in the presence of POPC and POPC/POPG LUVs, whereas Cnd-m3a seems to retain its initial random coil conformation in the presence of POPC LUVs and shows a very modest helical content in POPC/POPG LUVs. The percentage of α-helix is much higher in presence of POPC/POPG compared to POPC for Cnd-m3, the analog with higher antimicrobial activity, with a θ222nm molar ellipticity ratio of 0.40 (Table 2). For Cnd and Cnd-m3a, the ratio was ~1 indicating the same percentage of α-helix in both anionic and zwitterionic membranes. Interestingly, Cnd-m3a adopts a α-helix conformation, although to a lesser extent ~14% with respect to Cnd and Cnd-m3. This indicates that the introduction of the Lysine in position 9 in the middle of the non-polar face interfere with the ability to adopt and α-helical structure. Despite the different conformation adopted by Cnd-m3a and its different behavior with respect to the other two peptides in the presence of POPC and POPC/POPG vesicles, its antimicrobial activity is preserved. This is in accord with previous studies, which evidenced a different mode of action of the three peptides. In fact, while Cnd and Cnd-m3 have been described as membranolytic peptides, adopting an α-helical conformation to trigger their activity [30], we demonstrated that Cnd-m3a is able to traverse inner and outer membrane of Psychrobacter sp. targeting intracellular nuclei acids [31]. To get further insights into how primary structure can drive conformations, we carried out molecular dynamics simulations in different environments. MD simulations in presence of POPC and POPC/POPG bilayer agree with the experimental CD results and revealed the atomistic interactions between peptides and membranes. Cnd shows a higher content of helical structure with respect to the analogs in presence of both lipid bilayer of POPC and POPC/POPG. Cnd-m3 shows an increase of helical content moving from POPC to POPC/POPG, whereas Cnd-m3a does not show a significant change in the helical content in the presence of anionic component POPG in bilayer. The MD simulation validates that the substitution of Ile-9 with a lysine in Cnd-m3 with a lysine destabilizes the α-helix conformation in the N-terminal region of Cnd-m3a. MD simulations of the peptides absorbed on the surface of POPC bilayers emphasize that the peptides interact with the lipidic surface mainly through hydrophobic contacts. The presence of lysine residues helps to anchor the Cnd-m3 and Cnd-m3a to the surface of POPC/POPG bilayer through the formation of hydrogen bonds and ion-pairs with the phosphate group of lipids (Figure 4). Cnd, Cnd-m3, and Cnd-m3a embedded into bilayer perturb the organization of the lipids in the aggregates, especially for Cnd-m3 and Cnd-m3a due to the presence of lysine residues. The lysine residues in the hydrophobic core of lipid bilayer orient the positively charged head of side chains towards the surface (snorkeling effect) to obtain an energetically favorable interaction with the head groups of lipids. Cnd-m3 and Cnd-m3a induce a reorganization of lipid components close to peptides with a sensible reduction of the thickness of bilayer.

4. Materials and Methods

4.1. Materials

All lipids were purchased from Avanti polar Lipids (Alabaster, AL, USA). All peptides were purchased from CASLO ApS, c/o Scion Technical University of Denmark, with a purity >98%. Peptide concentrations were measured before each sample preparation by UV light absorption at 280 nm. Phosphate buffer pH 7.4 was used to diminish the UV absorbance in CD experiments.

4.2. Preparation of Lipid Vesicles

LUVs (Large Unilamellar Vesicles) were prepared as previously reported [29]. Lipids were dissolved in chloroform/methanol 9:1. The solvent was then removed by rotary evaporation and then overnight under high vacuum. The lipid film was then hydrated by adding 1 mL of buffer (20 mM phosphate buffer at pH 7.4 with 150 mM NaCl and 0.8 mM EDTA) and then subjected to 5 freeze-thaw cycles and vortexed. The multilamellar vesicles (MLVS) formed were extruded through a polycarbonate membrane with pore size of 100 nm using a mini extruder (Avanti Polar). The obtained LUVs were composed of 100% POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and of a 70/30 (w/w) combination of POPC/POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol). The final concentration of the lipid was 10 mM.

4.3. Circular Dichroism Spectroscopy

CD spectra were recorded in the 190–260 nm spectral range at 298 K on a J 715 JASCO spectropolarimeter equipped with a Peltier device for temperature control (0.5-cm path length quartz cuvette). Secondary structures of the three peptides were determined in phosphate buffer (PB) 0.01 M and EDTA 0.08 M at pH 7.4 in the absence and presence of LUVs of different composition. Peptides were prepared as 1.0 mM stock solution. A stock solution of LUVs (10 mM) was used. For LUVs interaction studies, solutions of 30 µM of Cnd and Chionodracine derived peptides were titrated with LUVs of different composition (100% POPC, 70:30 POPC:POPG) with a peptide/lipid ratio ranging from 1:0 to 1:60. Contribution from buffer and LUVs were removed by subtracting their spectra in the absence of peptides. The reported CD spectra are the average of 16 scans with a scanning speed of 20 nm/min, a response time of 8 s, a bandwidth of 1.0 nm and a step size of 0.1 nm. The obtained data in millidegrees (θ) were converted to mean molar ellipticities (deg cm2 dmol−1). The fractional helical content fα has been estimated using the formula [42]:
f α = θ θ R C θ H θ R C
where θ is the observed ellipticity at 222nm and θRC and θH are the limiting values for a completely random coil and α-helical conformation, respectively. At the temperature of 25 °C, according to the Luo and Baldwin formula [43], the limiting values of ellipticities are θ H =   39 , 375 and θ R C =   360 .

4.4. Steady-State Anisotropy Measurements

Lipids were dissolved in chloroform/methanol 9:1 and mixed with stock solution of DPH 1,6-Diphenyl-1,3,5-hexatriene. The molar ratio DPH/Lipids was 1:1000 and the LUVs were extruded as previously described. The anisotropy measurements were performed using a Perkin Elmer LS55. The temperature was set at 25 °C using a thermostatic cell holder controlled by an external bath circulator. The samples were excited at 380 nm and the emission was detected at 420 nm with an emission and absorption bandwidth of 5 nm [44]. Fluorescence anisotropy value, r, were obtained according to the equation:
r = I V V G * I V H I V V + 2 G * I V H
where IVV is the fluorescence measured with the excitation and emission polarizers oriented in the vertical position and IVH is the fluorescence intensity measured with the excitation polarizer oriented vertically and the emission oriented in horizontal position. G* is the correction grating factor, defined as the ratio between the vertically and horizontally polarized emission components upon excitation with a horizontally polarized light [45]. DPH acts as a rod-like hydrophobic probe rotating in the bilayer structure and located between the acyl chains of the lipids [46]. Changes in anisotropy values of DPH were used to evaluate membrane fluidity and peptide interaction with LUVs.

4.5. Computational Methods

4.5.1. Preparation of MD Simulations

The initial structure of Cnd was taken from the PDB structure resolved by NMR spectroscopy as described previously [29]. The three-dimensional structures of Cnd-m3 and Cnd-m3a has not been resolved yet by NMR spectroscopy. Therefore, we used the fold recognition algorithm implemented in I-TASSER (iterative threading assembly refinement algorithm) [47,48] to predict a 3D model of Cnd-m3 and Cnd-m3a starting from the amino acid sequence of target peptides. The best-scored model structures obtained by the I-TASSER prediction of Cnd-m3 and Cnd-m3a were used.
Titratable residues of peptides were modelled according to their protonation state in water at pH = 7.
The initial configuration of POPC and POPC/POPG (70:30) lipid bilayers was built by using PACKMOL program [49]. Each bilayer system was built with 128 lipids (64 per leaflet) and about 35 water molecules per lipid to have a fully hydrated bilayer. The mixed bilayer of POPC/POPG (70:30) was built by using 92 molecules of POPC and 36 molecules of POPG symmetrically distributed between the two bilayer leaflets. The lipid bilayers were equilibrated for 200 ns before the addition of peptides.
For each peptide six different simulation were performed:
(1) 
in water: the peptides were immersed in a cubic box (5.0 nm) and solvated with at list 4000 water molecules;
(2) 
in a mixture of TFE/water (30% v/v): the peptides were immersed in a cubic box (5.0 nm) and solvated with about 270 molecules of TFE and 2650 water molecules;
(3) 
with the peptide absorbed on lipid bilayer surface of POPC: the peptide was positioned above the pre-equilibrated bilayer surface of POPC with the helical axis parallel to the lipid surface with a distance of 0.5 nm between the center of mass of peptide and the phosphate atoms of lipids. A rectangular box of 6.5 × 6.5 × 8.0 nm3 was used with at list 5140 water molecules;
(4) 
with the peptide embedded in POPC lipid bilayer: the peptide was embedded in a pre-equilibrated lipid bilayer of POPC with the helical axis parallel to the normal of lipid bilayer in a rectangular box of 6.5 × 6.5 × 8.0 nm3 with at list 5140 water molecules;
(5) 
with the peptide absorbed on lipid bilayer surface of POPC:POPG: the peptide was positioned above the pre-equilibrated bilayer surface of POPC:POPG with the helical axis parallel to the lipid surface and a distance of 0.5 nm between the center of mass of peptide and the phosphate atoms of lipids. A rectangular box of 6.2 × 6.2 × 8.0 nm3 was used with at list 4300 water molecule;
(6) 
with the peptide embedded in POPC/POPG lipid bilayer: the peptide was embedded in a pre-equilibrated lipid bilayer of POPC/POPG (70:30) with the helical axis parallel to the normal of lipid bilayer in a rectangular box of 6.2 × 6.2 × 8.0 nm3 with at list 4300 water molecules.
For the simulation in water and in the mixture of TFE/water the NMR resolved structure of Cnd and the I-TASSER model of Cnd-m3 and Cnd-m3a was used. The structure of peptide obtained at the end of the MD simulation in TFE/water was used for the simulations in presence of lipid bilayer of POPC and POPC/POPG. The peptides were immersed in the hydrophobic region of lipid bilayer using the embedding protocol of M. Javanainen [50].
In all systems the appropriate number of chloride ions and sodium ions was used to neutralize the charges of the peptides and POPG molecules.

4.5.2. The MD Systems Setup

All MD simulations were carried out with GROMACS v.5.1.5 package [51]. The GROMOS G54a7 force field [52] was used to model the peptides molecules and ions in conjunction with the GROMOS-CKP [53,54,55] for the lipids. The phosphatidylglycerol component of the mixed lipid bilayer was a racemic mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-l-(1-glycerol) (L-POPG) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-d-(1-glycerol) (D-POPG). Water was modelled with the SPC model [56] and the force field proposed by Fioroni et al. [57] was used to describe TFE.
Lennard-Jones and electrostatic interactions were calculated using a cut-off of 1.2 nm and the long-range electrostatic interactions were accounted by using the particle mesh Ewald method (PME) [58].
All bonds were constrained using the P-LINCS algorithm [59,60] whereas the geometry of water molecules was fixed with the SETTLE algorithm [61]. The simulations were carried out with a time step of 2 fs.
The molecular systems were energy minimized and equilibrated as follows.
The systems were warmed up with five consecutive MD in the NVT ensemble from 100 K to 298 K in 500 ps with weak positional restraints on heavy atoms of peptides and lipids. Subsequently, 300 ns of unrestrained MD simulation in the NPT ensemble were performed for the peptides in water and in TFE/water whereas 400 ns of unrestrained MD (NPT) were performed for the peptides in presence of lipid bilayer. For each system two simulations with different random initial velocities were performed. The temperature of peptide, lipids, water and ions was kept constant separately at 298 K using the velocity rescale method [62] with a time constant of 0.1 ps. The pressure was controlled by using the Berendsen barostat [63] (P = 1 bar, τp = 1.0 ps). The pressure coupling was isotropic in the case of the simulations in water and in the mixture of TFE/water (30% v/v). In the simulation with lipid bilayer the pressure coupling was applied semi-isotropic: the z and the xy dimensions were allowed to vary independently.
Periodic boundary conditions were applied in all three dimensions.
A list of the simulations performed and details about the composition of the simulated systems are reported in Table S1.

4.5.3. The MD Analyses

The trajectories obtained by MD simulation were analysed with the GROMACS analysis tools, VMD 1.9.3 [64] and in-house scripts. The analysis of trajectories was performed on the last 100 ns of the simulations.
Analysis of the secondary structure was performed with gmx do_dssp tool of GROMACS using the program DSSP [65]. The time averaged local thickness of lipid bilayer was calculated using the g_lomepro tool considering the distance of phosphate atoms of lipids in opposite membrane leaflets [66].

5. Conclusions

In conclusion, our results highlight the interaction between Cnd and its analogues with anionic and zwitterionic membranes. Our studies showed that peptides are unstructured in water and fold, preferentially in α-helical structure, in presence of lipid vesicles of different compositions. Our computational studies confirmed the experimental results through a series of MD simulations of 400 ns time scale and showed at atomic resolution the effect of the mutations on the on the structure of peptides and their interaction with lipid membranes. While Cnd adopts a helical conformation both in POPC and POPC/POPG vesicles at low L:P ratio, Cnd-m3 shows a different behavior with the two types of bilayer, being more prone to adopt an α-helical in the presence of negatively charged vesicles. This correlates with previous partition studies evidencing a preference of Cnd-m3 toward POPC/POPG vesicles. The nutation of Ile-9 with a lysine in Cnd-m3, in the middle of the hydrophobic face, destabilizes the α-helix at the N-terminus and brings to a peptide, Cnd-m3a with completely different features. Overall this study lays the groundwork for the design of small peptides that can be used as an alternative to common antibiotics to reduce the risk of antibiotic resistance.

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/21/4/1401/s1.

Author Contributions

Conceptualization, S.B. and F.P.; Data curation, G.D.P., F.C. and F.B.; Formal analysis, S.B., C.O., F.B. and F.P.; Investigation, G.D.P. and F.C.; Methodology, S.B., G.D.P., F.C. and C.O.; Software, S.B.; Supervision, F.P.; Writing—original draft, S.B., F.C. and F.P.; Writing—review & editing, S.B. and F.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the “Departments of Excellence 2018” Program (Dipartimenti di Eccellenza) of the Italian ministry of Education, University and Research, DIBAF-Department of University of Tuscia, Project “Landscape 4.0—food, wellbeing and environment”.

Acknowledgments

In this section you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AMPAntimicrobial peptide
CDCircular dichroism
CndChionodracine
DPH1,6-Diphenyl-1,3,5-hexatriene
EDTAEthylenediaminetetraacetic acid
LUVLarge Unilamellar Vesicles
MDMolecular Dynamics
MDRMultidrug resistant
MICMinimum inhibitory concentration
MLVSMultilamellar vesicles
ODOptical Density
PBPhosphate buffer
POPC1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
POPG1-palmitoyl-2-oleoyl-sn-glycero-3-(1′-rac-glycerol) sodium salt
TFE2,2,2-Trifluoroethanol

References

  1. Cooper, M.A.; Shlaes, D. Fix the antibiotics pipeline. Nature 2011, 472, 32. [Google Scholar] [CrossRef]
  2. Administration, F.A.D. CFR Annual Print Title 21 food and Drugs. 2018. Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm (accessed on 19 July 2019).
  3. Baindara, P.; Mandal, S.M. Antimicrobial Peptides and Vaccine Development to Control Multi-drug Resistant Bacteria. Protein Pept. Lett. 2019, 26, 324–331. [Google Scholar] [CrossRef]
  4. Alvarez, A.; Fernandez, L.; Gutierrez, D.; Iglesias, B.; Rodriguez, A.; Garcia, P. Methicillin-resistant Staphylococcus aureus (MRSA) in hospitals: Latest trends and treatments based on bacteriophages. J. Clin. Microbiol. 2019. [Google Scholar] [CrossRef]
  5. Ghosh, C.; Sarkar, P.; Issa, R.; Haldar, J. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance. Trends Microbiol. 2019, 27, 323–338. [Google Scholar] [CrossRef]
  6. Boman, H.G. Antibacterial peptides: Basic facts and emerging concepts. J. Intern. Med. 2003, 254, 197–215. [Google Scholar] [CrossRef]
  7. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389–395. [Google Scholar] [CrossRef]
  8. Hancock, R.E.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nature Biotechnol. 2006, 24, 1551–1557. [Google Scholar] [CrossRef]
  9. Diamond, G.; Beckloff, N.; Weinberg, A.; Kisich, K.O. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 2009, 15, 2377–2392. [Google Scholar] [CrossRef] [Green Version]
  10. Zhang, S.K.; Song, J.W.; Gong, F.; Li, S.B.; Chang, H.Y.; Xie, H.M.; Gao, H.W.; Tan, Y.X.; Ji, S.P. Design of an alpha-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity. Sci. Rep. 2016, 6, 27394. [Google Scholar] [CrossRef] [Green Version]
  11. White, S.H.; Wimley, W.C. Hydrophobic interactions of peptides with membrane interfaces. Biochim. Biophys. Acta 1998, 1376, 339–352. [Google Scholar] [CrossRef] [Green Version]
  12. Chen, Y.; Mant, C.T.; Farmer, S.W.; Hancock, R.E.; Vasil, M.L.; Hodges, R.S. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280, 12316–12329. [Google Scholar] [CrossRef] [Green Version]
  13. Zelezetsky, I.; Tossi, A. Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 2006, 1758, 1436–1449. [Google Scholar] [CrossRef] [Green Version]
  14. Bartels, E.J.H.; Dekker, D.; Amiche, M. Dermaseptins, Multifunctional Antimicrobial Peptides: A Review of Their Pharmacology, Effectivity, Mechanism of Action, and Possible Future Directions. Front. Pharmacol. 2019, 10, 1421. [Google Scholar] [CrossRef] [Green Version]
  15. Latendorf, T.; Gerstel, U.; Wu, Z.; Bartels, J.; Becker, A.; Tholey, A.; Schroder, J.M. Cationic Intrinsically Disordered Antimicrobial Peptides (CIDAMPs) Represent a New Paradigm of Innate Defense with a Potential for Novel Anti-Infectives. Sci. Rep. 2019, 9, 3331. [Google Scholar] [CrossRef] [Green Version]
  16. Romero, S.M.; Cardillo, A.B.; Martinez Ceron, M.C.; Camperi, S.A.; Giudicessi, S.L. Temporins: An Approach of Potential Pharmaceutic Candidates. Surg. Infect. (Larchmt) 2019. [Google Scholar] [CrossRef]
  17. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev. 2006, 19, 491–511. [Google Scholar] [CrossRef] [Green Version]
  18. Silva, P.M.; Goncalves, S.; Santos, N.C. Defensins: Antifungal lessons from eukaryotes. Front. Microbiol. 2014, 5, 97. [Google Scholar] [CrossRef] [Green Version]
  19. Wimley, W.C.; Hristova, K. Antimicrobial peptides: Successes, challenges and unanswered questions. J. Membr. Biol. 2011, 239, 27–34. [Google Scholar] [CrossRef] [Green Version]
  20. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238–250. [Google Scholar] [CrossRef]
  21. Porcelli, F.; Ramamoorthy, A.; Barany, G.; Veglia, G. On the role of NMR spectroscopy for characterization of antimicrobial peptides. Methods Mol. Biol. 2013, 1063, 159–180. [Google Scholar]
  22. Shai, Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66, 236–248. [Google Scholar] [CrossRef] [PubMed]
  23. Aisenbrey, C.; Marquette, A.; Bechinger, B. The Mechanisms of Action of Cationic Antimicrobial Peptides Refined by Novel Concepts from Biophysical Investigations. Adv. Exp. Med. Biol. 2019, 1117, 33–64. [Google Scholar] [PubMed] [Green Version]
  24. Huang, H.W. Action of antimicrobial peptides: Two-state model. Biochemistry 2000, 39, 8347–8352. [Google Scholar] [CrossRef]
  25. Wimley, W.C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 2010, 5, 905–917. [Google Scholar] [CrossRef] [Green Version]
  26. Milne, D.J.; Fernandez-Montero, A.; Gundappa, M.K.; Wang, T.; Acosta, F.; Torrecillas, S.; Montero, D.; Zou, J.; Sweetman, J.; Secombes, C.J. An insight into piscidins: The discovery, modulation and bioactivity of greater amberjack, Seriola dumerili, piscidin. Mol. Immunol. 2019, 114, 378–388. [Google Scholar] [CrossRef]
  27. Noga, E.J.; Silphaduang, U. Piscidins: A novel family of peptide antibiotics from fish. Drug News Perspect. 2003, 16, 87–92. [Google Scholar] [CrossRef]
  28. Buonocore, F.; Randelli, E.; Casani, D.; Picchietti, S.; Belardinelli, M.C.; de Pascale, D.; De Santi, C.; Scapigliati, G. A piscidin-like antimicrobial peptide from the icefish Chionodraco hamatus (Perciformes: Channichthyidae) molecular characterization, localization and bactericidal activity. Fish Shellfish Immunol. 2012, 33, 1183–1191. [Google Scholar] [CrossRef]
  29. Olivieri, C.; Buonocore, F.; Picchietti, S.; Taddei, A.R.; Bernini, C.; Scapigliati, G.; Dicke, A.A.; Vostrikov, V.V.; Veglia, G.; Porcelli, F. Structure and membrane interactions of chionodracine, a piscidin-like antimicrobial peptide from the icefish Chionodraco hamatus. Biochim. Biophys. Acta 2015, 1848, 1285–1293. [Google Scholar] [CrossRef] [Green Version]
  30. Olivieri, C.; Bugli, F.; Menchinelli, G.; Veglia, G.; Buonocore, F.; Scapigliati, G.; Stocchi, V.; Ceccacci, F.; Papi, M.; Sanguinetti, M.; et al. Design and characterization of chionodracine-derived antimicrobial peptides with enhanced activity against drug-resistant human pathogens. RSC Adv. 2018, 8, 41331–41346. [Google Scholar] [CrossRef] [Green Version]
  31. Buonocore, F.; Picchietti, S.; Porcelli, F.; Della Pelle, G.; Olivieri, C.; Poerio, E.; Bugli, F.; Menchinelli, G.; Sanguinetti, M.; Bresciani, A.; et al. Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens. Dev. Comp. Immunol. 2019, 96, 9–17. [Google Scholar] [CrossRef]
  32. Dathe, M.; Nikolenko, H.; Meyer, J.; Beyermann, M.; Bienert, M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 2001, 501, 146–150. [Google Scholar] [CrossRef] [Green Version]
  33. Sudha, T.S.; Vijayakumar, E.K.; Balaram, P. Circular dichroism studies of helical oligopeptides. Can 3(10) and alpha-helical conformations be chiroptically distinguished? Int. J. Pept. Protein Res. 1983, 22, 464–468. [Google Scholar] [CrossRef]
  34. Manning, M.C.; Woody, R.W. Theoretical CD studies of polypeptide helices: Examination of important electronic and geometric factors. Biopolymers 1991, 31, 569–586. [Google Scholar] [CrossRef]
  35. Andersen, N.H.; Liu, Z.; Prickett, K.S. Efforts toward deriving the CD spectrum of a 3(10) helix in aqueous medium. FEBS Lett. 1996, 399, 47–52. [Google Scholar] [CrossRef] [Green Version]
  36. Sani, M.A.; Lee, T.H.; Aguilar, M.I.; Separovic, F. Proline-15 creates an amphipathic wedge in maculatin 1.1 peptides that drives lipid membrane disruption. Biochim. Biophys. Acta 2015, 1848, 2277–2289. [Google Scholar] [CrossRef] [Green Version]
  37. Plasek, J.; Jarolim, P. Interaction of the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene with biomembranes. Gen. Physiol. Biophys. 1987, 6, 425–437. [Google Scholar]
  38. Strandberg, E.; Killian, J.A. Snorkeling of lysine side chains in transmembrane helices: How easy can it get? FEBS Lett. 2003, 544, 69–73. [Google Scholar] [CrossRef] [Green Version]
  39. Wang, Z.; Wang, G. APD: The Antimicrobial Peptide Database. Nucleic Acids Res. 2004, 32, D590–D592. [Google Scholar] [CrossRef] [Green Version]
  40. Jiang, Z.; Vasil, A.I.; Gera, L.; Vasil, M.L.; Hodges, R.S. Rational design of alpha-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of charge, ‘specificity determinants’, total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio. Chem. Biol. Drug Des. 2011, 77, 225–240. [Google Scholar]
  41. Chen, Y.; Guarnieri, M.T.; Vasil, A.I.; Vasil, M.L.; Mant, C.T.; Hodges, R.S. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob. Agents Chemother. 2007, 51, 1398–1406. [Google Scholar] [CrossRef] [Green Version]
  42. Fernández-Vidal, M.; White, S.H.; Ladokhin, A.S. Membrane partitioning: “classical” and “nonclassical” hydrophobic effects. J. Membr. Biol. 2011, 239, 5–14. [Google Scholar] [CrossRef] [Green Version]
  43. Luo, P.; Baldwin, R.L. Mechanism of helix induction by trifluoroethanol: A framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. Biochemistry 1997, 36, 8413–8421. [Google Scholar] [CrossRef]
  44. Suzuki, M.; Miura, T. Effect of amyloid beta-peptide on the fluidity of phosphatidylcholine membranes: Uses and limitations of diphenylhexatriene fluorescence anisotropy. Biochim. Biophys. Acta 2015, 1848, 753–759. [Google Scholar] [CrossRef] [Green Version]
  45. Lakowicz, J.R. Principles of Fluorescence Spectroscopy; Springer: New York, NY, USA, 2009. [Google Scholar]
  46. do Canto, A.; Robalo, J.R.; Santos, P.D.; Carvalho, A.J.P.; Ramalho, J.P.P.; Loura, L.M.S. Diphenylhexatriene membrane probes DPH and TMA-DPH: A comparative molecular dynamics simulation study. Biochim. Biophys. Acta 2016, 1858, 2647–2661. [Google Scholar] [CrossRef]
  47. Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008, 9, 40. [Google Scholar] [CrossRef] [Green Version]
  48. Roy, A.; Kucukural, A.; Zhang, Y. I-TASSER: A unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5, 725–738. [Google Scholar] [CrossRef] [Green Version]
  49. Martinez, L.; Andrade, R.; Birgin, E.G.; Martinez, J.M. PACKMOL: A package for building initial configurations for molecular dynamics simulations. J. Comput. Chem. 2009, 30, 2157–2164. [Google Scholar] [CrossRef]
  50. Javanainen, M. Universal Method for Embedding Proteins into Complex Lipid Bilayers for Molecular Dynamics Simulations. J. Chem. Theory Comput. 2014, 10, 2577–2582. [Google Scholar] [CrossRef]
  51. Abraham, M.J.; Murtola, T.; Schulz, R.; Páll, S.; Smith, J.C.; Hess, B.; Lindahl, E. Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 2015, 1, 19–25. [Google Scholar] [CrossRef] [Green Version]
  52. Schmid, N.; Eichenberger, A.P.; Choutko, A.; Riniker, S.; Winger, M.; Mark, A.E.; van Gunsteren, W.F. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011, 40, 843–856. [Google Scholar] [CrossRef]
  53. Kukol, A. Lipid Models for United-Atom Molecular Dynamics Simulations of Proteins. J. Chem. Theory. Comput. 2009, 5, 615–626. [Google Scholar] [CrossRef] [Green Version]
  54. Poger, D.; Van Gunsteren, W.F.; Mark, A.E. A new force field for simulating phosphatidylcholine bilayers. J. Comput. Chem. 2010, 31, 1117–1125. [Google Scholar] [CrossRef]
  55. Poger, D.; Mark, A.E. On the Validation of Molecular Dynamics Simulations of Saturated and cis-Monounsaturated Phosphatidylcholine Lipid Bilayers: A Comparison with Experiment. J. Chem. Theory Comput. 2010, 6, 325–336. [Google Scholar] [CrossRef]
  56. Berendsen, H.J.C.; Postma, J.P.M.; van Gunsteren, W.F.; Hermans, J. Interaction Models for Water in Relation to Protein Hydration. In Intermolecular Forces; Reidel Publishing Company: Dordrecht, The Netherlands, 1981; pp. 331–342. [Google Scholar]
  57. Fioroni, M.; Burger, K.; Mark, A.E.; Roccatano, D. A new 2,2,2-Trifluoroethanol model for molecular dynamics simulations. J. Phys. Chem. B 2000, 104, 12347–12354. [Google Scholar] [CrossRef] [Green Version]
  58. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An Nlog(N) method for Ewald sums in large systems. J. Chem. Phys. 1993, 98, 10089–10092. [Google Scholar] [CrossRef] [Green Version]
  59. Hess, B.; Bekker, H.; Berendsen, H.J.C.; Fraaije, J.G.E.M. LINCS: A linear constraint solver for molecular simulations. J. Comp. Chem. 1997, 18, 1463–1472. [Google Scholar] [CrossRef]
  60. Hess, B. P-LINCS: A Parallel Linear Constraint Solver for Molecular Simulation. J. Chem. Theory Comput. 2007, 4, 116–122. [Google Scholar] [CrossRef]
  61. Miyamoto, S.; Kollman, P.A. SETTLE: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comp. Chem. 1992, 13, 952–962. [Google Scholar] [CrossRef]
  62. Bussi, G.; Donadio, D.; Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 2007, 126, 14101–14107. [Google Scholar] [CrossRef] [Green Version]
  63. Berendsen, H.J.C.; Postma, J.P.M.; van Gunsteren, W.F.; Di Nola, A.; Haak, J.R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 1984, 81, 3684–3690. [Google Scholar] [CrossRef] [Green Version]
  64. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38. [Google Scholar] [CrossRef]
  65. Kabsch, W.; Sander, C. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22, 2577–2637. [Google Scholar] [CrossRef] [PubMed]
  66. Gapsys, V.; de Groot, B.L.; Briones, R. Computational analysis of local membrane properties. J. Comput. Aided Mol. Des. 2013, 27, 845–858. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Helical net representation of Cnd and Cnd-mutants.
Figure 1. Helical net representation of Cnd and Cnd-mutants.
Ijms 21 01401 g001
Figure 2. CD spectra in buffer (black line) and in the presence of increasing amount of POPC (Top line) and POPC/POPG (Bottom line) vesicles. (A) Cnd, (B) Cnd-m3 and (C) Cnd-m3a. The P:L ratio ranges from 1:0 to 1:60.
Figure 2. CD spectra in buffer (black line) and in the presence of increasing amount of POPC (Top line) and POPC/POPG (Bottom line) vesicles. (A) Cnd, (B) Cnd-m3 and (C) Cnd-m3a. The P:L ratio ranges from 1:0 to 1:60.
Ijms 21 01401 g002
Figure 3. Fluorescence Anisotropy of DPH. Normalized fluorescence anisotropy of DPH in POPC and POPC/POPG lipid vesicles treated with Cnd (green), Cnd-m3 (blue) and Cnd-m3a (red). The data are shown as mean ± s.d. from experiments performed in quadruplicate.
Figure 3. Fluorescence Anisotropy of DPH. Normalized fluorescence anisotropy of DPH in POPC and POPC/POPG lipid vesicles treated with Cnd (green), Cnd-m3 (blue) and Cnd-m3a (red). The data are shown as mean ± s.d. from experiments performed in quadruplicate.
Ijms 21 01401 g003
Figure 4. Secondary structure of Cnd and Cnd mutants in water and in TFE/water as a function of simulating time. (A) Cnd in water, (B) Cnd in TFE/water (30% v/v), (C) Cnd-m3 in water, (D) Cnd-m3 in. TFE/water (30% v/v), (E) Cnd-m3a in water, (F) Cnd-m3a in TFE/water (30% v/v). The structures on the right are the initial (left) and the final conformations of peptides after 300 ns of MD simulation in the corresponding environment.
Figure 4. Secondary structure of Cnd and Cnd mutants in water and in TFE/water as a function of simulating time. (A) Cnd in water, (B) Cnd in TFE/water (30% v/v), (C) Cnd-m3 in water, (D) Cnd-m3 in. TFE/water (30% v/v), (E) Cnd-m3a in water, (F) Cnd-m3a in TFE/water (30% v/v). The structures on the right are the initial (left) and the final conformations of peptides after 300 ns of MD simulation in the corresponding environment.
Ijms 21 01401 g004
Figure 5. Snapshot MD simulation at 400 ns of (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC and (F) Cnd-m3a in POPC/POPG. The phosphate of the upper leaflet of bilayer is represented as violet dots. The residue of lysine, arginine and histidine are represented in blue stick whereas the hydrophobic amino acids are represented as orange stick. The water and counterions are omitted for clarity.
Figure 5. Snapshot MD simulation at 400 ns of (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC and (F) Cnd-m3a in POPC/POPG. The phosphate of the upper leaflet of bilayer is represented as violet dots. The residue of lysine, arginine and histidine are represented in blue stick whereas the hydrophobic amino acids are represented as orange stick. The water and counterions are omitted for clarity.
Ijms 21 01401 g005
Figure 6. Mass density profiles across lipid bilayer of lipid phosphate (orange), nitrogen atoms of choline (blue) and lysine residues (green) of (A) Cnd-m3 in POPC, (B) Cnd-m3 in POPC/POPG, (C) Cnd-m3a in POPC, (D) Cnd-m3a in POPC/POPG. The mass density is calculated with respect to the lipid bilayer center (z = 0).
Figure 6. Mass density profiles across lipid bilayer of lipid phosphate (orange), nitrogen atoms of choline (blue) and lysine residues (green) of (A) Cnd-m3 in POPC, (B) Cnd-m3 in POPC/POPG, (C) Cnd-m3a in POPC, (D) Cnd-m3a in POPC/POPG. The mass density is calculated with respect to the lipid bilayer center (z = 0).
Ijms 21 01401 g006
Figure 7. Snapshot at the end (400 ns) of MD simulations of Cnd, Cnd-m3 and Cnd-m3a embedded in lipid bilayer: (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC, (F) Cnd-m3a in POPC/POPG. The secondary structure of peptides is represented in cartoon and colored in red, lysine arginine, histidine and tryptophan are represented in blue sticks. The lipid molecules are represented in thin sticks and colored according to their atom types (red for oxygen, blue for nitrogen, orange for phosphate atoms, green for carbon atoms of POPC, yellow for carbon atoms of POPG). The lipid molecules within 3.5 Å from the peptide atoms are represented in sticks. Water molecules in the hydrophobic region of lipid are represented in ball-sticks. The water surface is generated using the VMD Surf representation.
Figure 7. Snapshot at the end (400 ns) of MD simulations of Cnd, Cnd-m3 and Cnd-m3a embedded in lipid bilayer: (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC, (F) Cnd-m3a in POPC/POPG. The secondary structure of peptides is represented in cartoon and colored in red, lysine arginine, histidine and tryptophan are represented in blue sticks. The lipid molecules are represented in thin sticks and colored according to their atom types (red for oxygen, blue for nitrogen, orange for phosphate atoms, green for carbon atoms of POPC, yellow for carbon atoms of POPG). The lipid molecules within 3.5 Å from the peptide atoms are represented in sticks. Water molecules in the hydrophobic region of lipid are represented in ball-sticks. The water surface is generated using the VMD Surf representation.
Ijms 21 01401 g007
Figure 8. Time average of the last 100 ns of simulations of POPC and POPC/POPG local lipid bilayer thickness in presence of antimicrobial peptides embedded in to lipid bilayer: (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC, (F) Cnd-m3a in POPC/POPG. The thickness increases as a blue-white-red color gradient.
Figure 8. Time average of the last 100 ns of simulations of POPC and POPC/POPG local lipid bilayer thickness in presence of antimicrobial peptides embedded in to lipid bilayer: (A) Cnd in POPC, (B) Cnd in POPC/POPG, (C) Cnd-m3 in POPC, (D) Cnd-m3 in POPC/POPG, (E) Cnd-m3a in POPC, (F) Cnd-m3a in POPC/POPG. The thickness increases as a blue-white-red color gradient.
Ijms 21 01401 g008
Table 1. Sequence and physicochemical characteristics of chionodracines.
Table 1. Sequence and physicochemical characteristics of chionodracines.
PeptideSequenceNet ChargepI(μH)
CndWFGHLYRGITSVVKHVHGLLSG+29.990.574
Cnd-m3WFGKLYRGITKVVKKVKGLLKG+710.580.684
Cnd-m3aWFGKLYRGKTKVVKKVKGLLKG+810.820.564
Table 2. Helicity in presence of different LUVs environment calculated according to the formula (1) derived by Luo and Baldwin.
Table 2. Helicity in presence of different LUVs environment calculated according to the formula (1) derived by Luo and Baldwin.
POPCPOPC/POPG (70:30)POPC vs. POPC/POPG
θ222nm% helicityθ222nm% helicity θ 222 n m P C / θ 222 n m P C P G
Cnd−24,90062.8−25,50064.40.98
Cnd-m3−12,30030.6−31,00078.50.40
Cnd-m3a−500011.9−510014.00.98

Share and Cite

MDPI and ACS Style

Borocci, S.; Della Pelle, G.; Ceccacci, F.; Olivieri, C.; Buonocore, F.; Porcelli, F. Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations. Int. J. Mol. Sci. 2020, 21, 1401. https://doi.org/10.3390/ijms21041401

AMA Style

Borocci S, Della Pelle G, Ceccacci F, Olivieri C, Buonocore F, Porcelli F. Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations. International Journal of Molecular Sciences. 2020; 21(4):1401. https://doi.org/10.3390/ijms21041401

Chicago/Turabian Style

Borocci, Stefano, Giulia Della Pelle, Francesca Ceccacci, Cristina Olivieri, Francesco Buonocore, and Fernando Porcelli. 2020. "Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations" International Journal of Molecular Sciences 21, no. 4: 1401. https://doi.org/10.3390/ijms21041401

APA Style

Borocci, S., Della Pelle, G., Ceccacci, F., Olivieri, C., Buonocore, F., & Porcelli, F. (2020). Structural Analysis and Design of Chionodracine-Derived Peptides Using Circular Dichroism and Molecular Dynamics Simulations. International Journal of Molecular Sciences, 21(4), 1401. https://doi.org/10.3390/ijms21041401

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop